Cycad Group
Cycad Group is a venture capital firm focused on investing in technology companies. Their investment strategy involves making early-stage initial investments and participating in follow-on financings to support portfolio companies' growth. They prefer to co-invest with other experienced investors and seek opportunities where technology and market risks have been addressed. Cycad Group acts as a partner to its portfolio companies, providing support and resources beyond capital investment.
Cycad Group
What We Do
Cycad Group provides enthusiastic support and constructive criticism to its portfolio companies. They act as active advisors, assisting management in the development and execution of business and financial strategies. They often seek board observation rights or the right to designate a representative to the board of directors of a portfolio company.
Geographic Focus
Industry Focus
Show More (3)Portfolio
Advanced Bionics has been acquired by Boston Scientific Corporation.
#Neurostimulation
Agile has exclusively licensed certain of its key technologies to TriQuint.
#Wireless Communications
Alsius has been acquired by a wholly-owned subsidiary of ZOLL Medical Corporation.
#Medical Devices
Renovis acquired Centaur Pharmaceuticals, Inc. in December 2002.
#Pharmaceuticals
The Seraph 100 blood filter received CE Mark approval in the EU in 2019 and is available for the treatment of COVID-19 in the US under an FDA Emergency Use Authorization.
#Medical Devices
MacLean Fogg has acquired Formetrix Metal’s proprietary, high performance steel alloy powders for additive manufacturing.
#3D Printing
FzioMed’s product platform is an innovative polymer technology called Oxiplex® for the prevention of post-surgical adhesions.
#Biosurgery
Genocea uses its proprietary technology platform, ATLAS™, to develop neoantigen cancer vaccines.
#Biotechnology
ImaginAb’s technology enables antibodies to be re-engineered into smaller proteins for diagnostic imaging.
#Diagnostics
Intarcia is developing therapies utilizing its Medici Drug Delivery System™ to target Type 2 Diabetes.
#Biotechnology
Lixivia applies proprietary processes to improve the recovery of minerals from industrial waste products.
#Materials
Sofie combines novel tools for PET imaging and radiosynthesis with a full line of imaging and radiochemistry systems.
#Imaging
Solaria manufactures low-concentration photovoltaic modules for ground-mounted tracking systems.
#Renewable Energy
U.S. Steel has acquired Nanosteel’s advanced sheet steel intellectual property and trademarks.
#Materials
TPX is focused on oil and gas exploration and development in the Arkoma Basin of southeastern Oklahoma.
#Oil and Gas
Unity focuses on developing therapeutics that extend the human healthspan through intervention in the biological mechanisms associated with aging.
#Biotechnology